Metabolic Neurology, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, United Kingdom.
JAMA Ophthalmol. 2020 Dec 1;138(12):1264-1271. doi: 10.1001/jamaophthalmol.2020.4242.
There is an unmet need for noninvasive biomarkers of intracranial pressure (ICP), which manifests as papilledema that can be quantified by optical coherence tomography (OCT) imaging.
To determine whether OCT of the optic nerve head in papilledema could act as a surrogate measure of ICP.
DESIGN, SETTING, AND PARTICIPANTS: This longitudinal cohort study used data collected from 3 randomized clinical trials that were conducted between April 1, 2014, and August 1, 2019. Participants who were female and had active idiopathic intracranial hypertension were enrolled from 5 National Health Service hospitals in the UK. Automated perimetry and OCT imaging were followed immediately by ICP measurement on the same day. Cohort 1 used continuous sitting telemetric ICP monitoring (Raumedic Neurovent P-tel device) on 1 visit. Cohort 2 was evaluated at baseline and after 3, 12, and 24 months and underwent lumbar puncture assessment of ICP.
Optical coherence tomography measures of the optic nerve head and macula were correlated with ICP levels, Frisén grading, and perimetric mean deviation. The OCT protocol included peripapillary retinal nerve fiber layer, optic nerve head, and macular volume scans (Spectralis [Heidelberg Engineering]). All scans were validated for quality and resegmented manually when required.
A total of 104 women were recruited. Among cohort 1 (n = 15; mean [SD] age, 28.2 [9.4] years), the range of OCT protocols was evaluated, and optic nerve head central thickness was found to be most closely associated with ICP (right eye: r = 0.60; P = .02; left eye: r = 0.73; P = .002). Subsequently, findings from cohort 2 (n = 89; mean [SD] age, 31.8 [7.5] years) confirmed the correlation between central thickness and ICP longitudinally (12 and 24 months). Finally, bootstrap surrogacy analysis noted a positive association between central thickness and change in ICP at all points (eg, at 12 months, a decrease in central thickness of 50 μm was associated with a decrease in ICP of 5 cm H2O).
In this study, optic nerve head volume measures on OCT (particularly central thickness) reproducibly correlated with ICP and surrogacy analysis demonstrated its ability to inform ICP changes. These data suggest that OCT has the utility to not only monitor papilledema but also noninvasively prognosticate ICP levels in idiopathic intracranial hypertension.
目前需要一种非侵入性的颅内压(ICP)生物标志物,其表现为视乳头水肿,可以通过光学相干断层扫描(OCT)成像进行量化。
确定视乳头水肿的视神经头 OCT 是否可以作为 ICP 的替代测量方法。
设计、地点和参与者:这是一项纵向队列研究,使用了 2014 年 4 月 1 日至 2019 年 8 月 1 日期间进行的 3 项随机临床试验的数据。参与者为女性,患有活动性特发性颅内高压,在英国的 5 家国民保健服务医院招募。在同一天,自动视野计和 OCT 成像后立即进行 ICP 测量。队列 1 在 1 次就诊时使用连续坐位遥测 ICP 监测(RaumedicNeuroventP-tel 设备)。队列 2 在基线和 3、12 和 24 个月时进行评估,并进行腰椎穿刺评估 ICP。
视神经头和黄斑的 OCT 测量值与 ICP 水平、Frisén 分级和视野平均偏差相关。OCT 方案包括视盘周围视网膜神经纤维层、视神经头和黄斑体积扫描(Spectralis [海德堡工程])。所有扫描均经过质量验证,并在需要时手动重新分段。
共招募了 104 名女性。在队列 1(n=15;平均[标准差]年龄,28.2[9.4]岁)中,评估了 OCT 方案的范围,发现视神经头中央厚度与 ICP 最密切相关(右眼:r=0.60;P=0.02;左眼:r=0.73;P=0.002)。随后,队列 2(n=89;平均[标准差]年龄,31.8[7.5]岁)的结果证实了中央厚度与 ICP 的纵向相关性(12 个月和 24 个月)。最后,bootstrap 代理分析注意到中央厚度与各个点的 ICP 变化之间存在正相关(例如,在 12 个月时,中央厚度减少 50μm 与 ICP 减少 5cmH2O 相关)。
在这项研究中,OCT 上的视神经头容积测量值(特别是中央厚度)与 ICP 重现性相关,并且代理分析表明其能够提供 ICP 变化的信息。这些数据表明,OCT 不仅具有监测视乳头水肿的功能,而且还可以无创性预测特发性颅内高压的 ICP 水平。